NHP National Healthcare Properties, Inc.
Real Estate Investment Trusts · Nasdaq · SEC CIK 1561032 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.6%
TTM net income YoY76.5%
TTM EPS YoY61.9%
Revenue 3-yr CAGR1.6%
Net income 3-yr CAGR—
Margins
Gross margin36.5%
Operating margin11.2%
Net margin-3.4%
FCF margin—
EBITDA margin32.8%
Returns
ROE-1.6%
ROA-0.7%
ROIC (approx.)4.8%
Asset turnover0.20x
Leverage & solvency
Liabilities / assets51.9%
Debt / equity0.00x
Current ratio—
Interest coverage0.73x
Cash quality & payout
Operating cash flow / net income-4.62x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $342.28M | $353.79M | $345.93M | $335.85M | $329.36M |
| Gross profit | $123.38M | $132.34M | $128.13M | $122.40M | $123.54M |
| SG&A expense | $24.19M | $22.44M | $18.93M | $17.29M | $16.83M |
| Operating income | $3.30M | -$123.54M | -$4.74M | -$31.54M | -$37.44M |
| Interest expense | $61.28M | $69.45M | $66.08M | $51.74M | $47.90M |
| Pretax income | -$57.52M | -$190.00M | -$72.08M | -$79.42M | -$85.24M |
| Income tax | $161,000 | $262,000 | $303,000 | $201,000 | $203,000 |
| Net income | -$57.62M | -$189.70M | -$72.30M | -$79.49M | -$85.18M |
| EBITDA | $81.56M | -$39.47M | $78.14M | $50.52M | $42.49M |
| EPS (basic) | -2.51 | -7.19 | -3.04 | -3.30 | -0.82 |
| EPS (diluted) | -2.51 | -7.19 | -3.04 | -3.30 | -0.82 |
| Dividends declared per share | — | 0.85 | 0.85 | 0.85 | — |
| Weighted avg. shares (diluted) | 28.30M | 28.29M | 28.28M | 28.26M | 112.97M |
| Balance sheet | |||||
| Cash & equivalents | $57.62M | $74.09M | $46.41M | $76.54M | $85.38M |
| Intangibles | $246.54M | $55.37M | $69.25M | $80.69M | $93.08M |
| Total assets | $1.71B | $1.95B | $2.15B | $2.18B | $2.21B |
| Total liabilities | $1.11B | $1.26B | $1.24B | $1.18B | $1.17B |
| Shareholders' equity | $600.06M | $684.56M | $894.15M | $992.64M | $1.03B |
| Shares outstanding | 28.43M | 28.30M | 27.89M | 26.27M | 99.28M |
| Cash flow statement | |||||
| Operating cash flow | $6.95M | -$79.85M | $21.62M | $28.30M | $38.88M |
| Investing cash flow | $69.81M | $63.97M | -$62.82M | -$41.78M | -$47.92M |
| Financing cash flow | -$42.40M | -$1.35M | $55.97M | $4.64M | $4.08M |
| Depreciation & amortization | $78.26M | $84.07M | $82.87M | $82.06M | $79.93M |
| Stock-based compensation | $3.77M | $613,000 | $919,000 | $1.19M | $1.33M |
| Dividends paid | — | — | — | $0 | $0 |
| Share buybacks | — | — | — | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 13 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.